Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 352.21M | 374.84M | 300.81M | 254.88M | 137.00M |
Gross Profit | 190.20M | 214.34M | 156.35M | 134.41M | 21.54M |
EBITDA | 111.28M | 112.96M | 52.77M | 74.16M | -69.41M |
Net Income | 26.06M | 25.34M | -22.80M | -22.33M | -143.78M |
Balance Sheet | |||||
Total Assets | 830.40M | 814.67M | 821.15M | 883.25M | 997.75M |
Cash, Cash Equivalents and Short-Term Investments | 100.59M | 76.20M | 97.40M | 189.71M | 317.38M |
Total Debt | 266.26M | 252.06M | 263.02M | 226.11M | 305.68M |
Total Liabilities | 452.18M | 469.08M | 491.39M | 452.88M | 532.98M |
Stockholders Equity | 299.47M | 273.14M | 263.36M | 356.08M | 385.49M |
Cash Flow | |||||
Free Cash Flow | 29.62M | 25.78M | -15.30M | -11.71M | -32.27M |
Operating Cash Flow | 70.84M | 58.62M | 17.32M | 6.07M | -23.01M |
Investing Cash Flow | -41.22M | -31.79M | -53.29M | -7.00K | -9.26M |
Financing Cash Flow | -6.04M | -48.53M | -58.51M | -132.72M | 240.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $1.36B | 41.98 | 11.16% | ― | 1.25% | 55.54% | |
65 Neutral | $2.98B | 14.20 | 70.99% | 0.62% | 13.80% | 109.00% | |
62 Neutral | $1.75B | 13.49 | 1222.83% | ― | 5.81% | 133.05% | |
61 Neutral | $41.44B | -3.01 | -10.30% | 3.97% | 2.71% | -44.19% | |
49 Neutral | $1.23B | ― | 20.03% | ― | -5.43% | 26.07% | |
47 Neutral | $1.93B | ― | 168.75% | ― | -2.85% | 75.96% | |
42 Neutral | $1.93B | ― | 259.47% | ― | -2.85% | 75.96% |
On July 17, 2025, IMAX Corporation announced an amendment to the employment agreement of its CEO, Richard L. Gelfond, extending his term until December 31, 2028. The amendment outlines his compensation, including a base salary of $1.2 million, potential bonuses, and equity awards contingent on performance metrics. The agreement also details conditions for severance and equity vesting, ensuring continuity in leadership and aligning executive incentives with company performance goals.
The most recent analyst rating on (IMAX) stock is a Hold with a $26.00 price target. To see the full list of analyst forecasts on IMAX stock, see the IMAX Stock Forecast page.
On July 14, 2025, IMAX Corporation entered into a Seventh Amended and Restated Credit Agreement with Wells Fargo Bank and other lenders, increasing its revolving borrowing capacity to $375 million, with potential expansion to $515 million or more. The agreement, which matures in 2030, includes various financial covenants and is secured by the company’s assets. The proceeds are intended for working capital and general corporate purposes, with $52 million used to repay previous credit facility balances.
The most recent analyst rating on (IMAX) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on IMAX stock, see the IMAX Stock Forecast page.
On June 11, 2025, IMAX Corporation held its Annual General Meeting where shareholders elected directors, approved PricewaterhouseCoopers LLP as auditors, and endorsed executive compensation. On June 12, 2025, IMAX announced a $100 million increase to its share repurchase program, extending it through June 30, 2027, bringing the total authorization to $500 million. This move reflects IMAX’s strategic focus on enhancing shareholder value and maintaining a strong market position.
The most recent analyst rating on (IMAX) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on IMAX stock, see the IMAX Stock Forecast page.